Evidence map›Paper›PMID 36551835›Full record

ReviewBiomedicines2022

The Functional Properties and Physiological Roles of Signal-Transducing Adaptor Protein-2 in the Pathogenesis of Inflammatory and Immune Disorders.

Jun-Ichi Kashiwakura, Kenji Oritani, Tadashi Matsuda

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07751393 (Investigation of the Role of Signal-Transducing Adaptor Proteins in Periodontal Disease), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07751393 completednot on this mapstarted 2024, after this paper: background citation

Investigation of the Role of Signal-Transducing Adaptor Proteins in Periodontal Disease

TypeobservationalSponsorInonu UniversityRan2024 to 2024Enrolled75ConditionsPeriodontitis, Gingivitis
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. STAP2 promotes the progression of renal fibrosis via HSP27.Journal of translational medicine · 2024
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Jun-Ichi KashiwakuraDepartment of Life Science, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo 0068585, Hokkaido, Japan.ORCID 0000-0002-7863-6696
Kenji OritaniDepartment of Hematology, International University of Health and Welfare, Narita 2868686, Chiba, Japan.
Tadashi MatsudaDepartment of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo 0600812, Hokkaido, Japan.ORCID 0000-0002-3089-3757
Hokkaido University · JPHokkaido University of Science · JPInternational University of Health and Welfare · JP

Funding

Japan Society for the Promotion of Science 19H03364Japan Society for the Promotion of Science 21K08451
6 · The paper itself

Abstract

Adaptor molecules play a crucial role in signal transduction in immune cells. Several adaptor molecules, such as the linker for the activation of T cells (LAT) and SH2 domain-containing leukocyte protein of 76 kDa (SLP-76), are essential for T cell development and activation following T cell receptor (TCR) aggregation, suggesting that adaptor molecules are good therapeutic targets for T cell-mediated immune disorders, such as autoimmune diseases and allergies. Signal-transducing adaptor protein (STAP)-2 is a member of the STAP family of adaptor proteins. STAP-2 functions as a scaffold for various intracellular proteins, including BRK, signal transducer, and activator of transcription (STAT)3, STAT5, and myeloid differentiation primary response protein (MyD88). In T cells, STAP-2 is involved in stromal cell-derived factor (SDF)-1α-induced migration, integrin-dependent cell adhesion, and Fas-mediated apoptosis. We previously reported the critical function of STAP-2 in TCR-mediated T cell activation and T cell-mediated autoimmune diseases. Here, we review how STAP-2 affects the pathogenesis of T cell-mediated inflammation and immune diseases in order to develop novel STAP-2-targeting therapeutic strategies.

Indexed as

immune responsesignal-transducing adaptor protein-2 (STAP-2)signal transductionT cell antigen receptor (TCR)T cells

Identifiers

PMID36551835
PMCPMC9776019
OpenAlexW4310478451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.